Quarterly Financial Update for InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV)


InVivo Therapeutics Holdings Corp. (NVIV) reported earning per shares for the quarter ending Aug 10, whereas, 2 number of analysts estimated the mean EPS at -0.22. The analysts estimated EPS for the higher end at -0.21 and lower end at -0.22 while the year ago reported earnings per share was -0.2.

The company has mean EPS estimate of -0.19 reported by 2 number of analyst for the quarter ending Current Qtr.(Sep2017). The analysts estimated mean EPS at -0.19 while the high and low EPS estimate stand at -0.17 and -0.2 respectively. In contrast to the year ago quarter EPS was at -0.22.

Valuation Ratios of InVivo Therapeutics Holdings Corp. (NVIV) versus the Industry and Sector:

Let’s have a look at some of the important valuation ratios of the InVivo Therapeutics Holdings Corp. (NVIV). These ratios are important while doing valuation of the company or the shares of the company.

InVivo Therapeutics Holdings Corp. (NVIV) currently the company’s industry has 121.36 P/E and the sector P/E is 33.54. Similarly, the company’s last 5 years high P/E ratio is 26.83 and low P/E is 26.83, whereas, the industry’s and sector’s  high P/E for the past year is 72.63 and 44.26 respectively and low P/E ratio for the last 5 years is 21.54 for the industry and 24.62 for the Sector.

Beta is also an important valuation ratio for analyzing the stock of the company, NVIV has Beta of 3 while its industry and Sector’s beta remains at 0.91 and 0.95 respectively.

Price to Book Ratio stands at 2.35. The industry and sector ratio of Price to Cash Flow ticked at 18.77 and 24.54 respectively.

5 Year Growth Rate Analysis:

Growth rates are very important while analyzing the long term growth and valuation of a certain company.

5 year sales growth rate is an important factor for valuation analysis, the industry’s and the sector’s growth for next 5 years ticked at 3.3 and 10.56 respectively.

InVivo Therapeutics Holdings Corp. (NVIV) Trading Statistics:

The company declined -30% and closed its last trading session at $1.75. The market capitalization of the company is at $41.58 Million. The stock touched 52-week High of $7.94 on 08/23/16 and 52-week Low of $1.48 on 08/10/17. The stock currently has Weekly Volatility of 17.31% and Monthly Volatility of 11.64%. The Beta for the company stands at 2.98 and its Average True Range (ATR) shows a value of 0.25.